SHOX2 DNA Methylation is a Biomarker for the diagnosis of lung cancer based on bronchial aspirates
<p>Abstract</p> <p>Background</p> <p>This study aimed to show that SHOX2 DNA methylation is a tumor marker in patients with suspected lung cancer by using bronchial fluid aspirated during bronchoscopy. Such a biomarker would be clinically valuable, especially when, foll...
Main Authors: | Liloglou Triantafillos, Wille Ulrike, Weickmann Sabine, Tetzner Reimo, Distler Jürgen, Lewin Jörn, Seemann Stefanie, Flemming Nadja, Seegebarth Anke, Schlegel Thomas, Kneip Christoph, Dietrich Dimo, Liebenberg Volker, Schmidt Bernd, Raji Olaide, Walshaw Martin, Fleischhacker Michael, Witt Christian, Field John K |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2010-11-01
|
Series: | BMC Cancer |
Online Access: | http://www.biomedcentral.com/1471-2407/10/600 |
Similar Items
-
Quantification of cell-free mSHOX2 Plasma DNA for therapy monitoring in advanced stage non-small cell (NSCLC) and small-cell lung cancer (SCLC) patients.
by: Bernd Schmidt, et al.
Published: (2015-01-01) -
A combined HM-PCR/SNuPE method for high sensitive detection of rare DNA methylation
by: Tierling Sascha, et al.
Published: (2010-06-01) -
Clinical Evidence of Crossover in the SHOX Gene
by: Emine Göktaş, et al.
Published: (2021-01-01) -
Rare dosage abnormalities flanking the SHOX gene
by: David J. Bunyan, et al.
Published: (2021-12-01) -
Genetic Analysis and Sonography Characteristics in Fetus with SHOX Haploinsufficiency
by: Lushan Li, et al.
Published: (2023-01-01)